Global Health Limited (IN:MEDANTA)
:MEDANTA
Want to see IN:MEDANTA full AI Analyst Report?
Total Valuation
Global Health Limited has a market cap or net worth of ₹333.70B. The enterprise value is ₹334.00B.
Market Cap₹333.70B
Enterprise Value₹334.00B
Share Statistics
Global Health Limited has 268,851,870 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding268,851,870
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Global Health Limited’s return on equity (ROE) is 0.14 and return on invested capital (ROIC) is 10.11%.
Return on Equity (ROE)0.14
Return on Assets (ROA)0.09
Return on Invested Capital (ROIC)10.11%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee4.87M
Profits Per Employee614.74K
Employee Count9,052
Asset Turnover0.75
Inventory Turnover29.32
Valuation Ratios
The current PE Ratio of Global Health Limited is 46.4. Global Health Limited’s PEG ratio is 2.98.
PE Ratio46.4
PS Ratio5.86
PB Ratio6.52
Price to Fair Value6.52
Price to FCF-114.57
Price to Operating Cash Flow101.40
PEG Ratio2.98
Income Statement
In the last 12 months, Global Health Limited had revenue of 44.10B and earned 5.56B in profits. Earnings per share was 20.71.
Revenue44.10B
Gross Profit20.95B
Operating Income6.97B
Pretax Income7.15B
Net Income5.56B
EBITDA9.19B
Earnings Per Share (EPS)20.71
Cash Flow
In the last 12 months, operating cash flow was 3.29B and capital expenditures -4.13B, giving a free cash flow of -841.82M billion.
Operating Cash Flow3.29B
Free Cash Flow-841.82M
Free Cash Flow per Share-3.13
Dividends & Yields
Global Health Limited pays an annual dividend of ₹0.5, resulting in a dividend yield of 0.04%
Dividend Per Share₹0.5
Dividend Yield0.04%
Payout Ratio2.28%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.58
52-Week Price Change5.10%
50-Day Moving Average1.10K
200-Day Moving Average1.21K
Relative Strength Index (RSI)65.68
Average Volume (3m)17.50K
Important Dates
Global Health Limited upcoming earnings date is Aug 6, 2026, Before Open (Confirmed).
Last Earnings DateMay 14, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Global Health Limited as a current ratio of 2.67, with Debt / Equity ratio of 30.04%
Current Ratio2.67
Quick Ratio2.54
Debt to Market Cap0.03
Net Debt to EBITDA0.07
Interest Coverage Ratio8.80
Taxes
In the past 12 months, Global Health Limited has paid 1.61B in taxes.
Income Tax1.61B
Effective Tax Rate0.23
Enterprise Valuation
Global Health Limited EV to EBITDA ratio is 28.16, with an EV/FCF ratio of -114.84.
EV to Sales5.87
EV to EBITDA28.16
EV to Free Cash Flow-114.84
EV to Operating Cash Flow34.37
Balance Sheet
Global Health Limited has ₹12.55B in cash and marketable securities with ₹9.45B in debt, giving a net cash position of ₹3.10B billion.
Cash & Marketable Securities₹12.55B
Total Debt₹9.45B
Net Cash₹3.10B
Net Cash Per Share₹11.52
Tangible Book Value Per Share₹148.28
Margins
Gross margin is 69.43%, with operating margin of 15.79%, and net profit margin of 12.62%.
Gross Margin69.43%
Operating Margin15.79%
Pretax Margin16.21%
Net Profit Margin12.62%
EBITDA Margin20.84%
EBIT Margin15.79%
Analyst Forecast
The average price target for Global Health Limited is ₹1,500.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹1,500.00
Price Target Upside23.29% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast19.44%
EPS Growth Forecast15.55%